Functional selectivity of central Gα-subunit proteins in mediating the cardiovascular and renal excretory responses evoked by central α 2-adrenoceptor activation in vivo

British Journal of Pharmacology

Volumn 166, Issue 1, 2012, Pages 210-220

  Wainford, Richard D ^a   Kapusta, D R ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 adrenoceptor; Brain G subunit proteins; cardiovascular function; CNS; GPCR; guanabenz; renal excretory function

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; GUANABENZ; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HEART RATE; HYPOTENSION; IMMUNOBLOTTING; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; URINARY EXCRETION; URINE FLOW RATE;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; BLOOD PRESSURE; BRAIN; GTP-BINDING PROTEIN ALPHA SUBUNITS; GUANABENZ; HEART RATE; INJECTIONS, INTRAVENTRICULAR; MALE; OLIGODEOXYRIBONUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; SIGNAL TRANSDUCTION;

EID: 84859726327     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01662.x     Document Type: Article

References (35)

1. Albarran-Juarez J, Gilsbach R, Piekorz RP, Pexa K, Beetz N, Schneider J, et al,. (2009). Modulation of alpha2-adrenoceptor functions by heterotrimeric Galphai protein isoforms. J Pharmacol Exp Ther 331: 35-44.
2. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
3. Bensimon M, Chang AI, de Bold ML, Ponce A, Carreras D, De Bold AJ, (2004). Participation of G proteins in natriuretic peptide hormone secretion from heart atria. Endocrinology 145: 5313-5321.
4. Brooks DP, Share L, Crofton JT, (1986). Central adrenergic control of vasopressin release. Neuroendocrinology 42: 416-420.
5. Cabral AD, Kapusta DR, Kenigs VA, Varner KJ, (1998). Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia. Am J Physiol 275: R1867-R1874.
6. Chen CH, Chan SH, (1989). Involvement of postsynaptic alpha 2-adrenoceptors and guanine nucleotide-binding protein in guanabenz-induced cardiovascular suppressant effects in the rat. Neurosci Lett 105: 183-188.
7. Degoute CS, (2007). Controlled hypotension: a guide to drug choice. Drugs 67: 1053-1076.
8. i proteins contribute different components of adrenergic inhibition of Ca2+ channels in rat sympathetic neurons. J Physiol 518: 23-36.
9. 2A-adrenergic receptor. Evidence for distinct structural determinants that confer Gs versus Gi coupling. J Biol Chem 270: 24753-24760.
10. Gellai M, Edwards RM, (1988). Mechanism of alpha 2-adrenoceptor agonist-induced diuresis. Am J Physiol 255: F317-F323.
11. Grisk O, DiBona GF, (1998). Influence of arterial baroreceptors and intracerebroventricular guanabenz on synchronized renal nerve activity. Acta Physiol Scand 163: 209-218.
12. Hadjimarkou MM, Silva RM, Rossi GC, Pasternak GW, Bodnar RJ, (2002). Feeding induced by food deprivation is differentially reduced by G-protein alpha-subunit antisense probes in rats. Brain Res 955: 45-54.
13. Hein L, (2006). Adrenoceptors and signal transduction in neurons. Cell Tissue Res 326: 541-551.
14. Huang BS, Leenen FH, (1994). Brain 'ouabain' mediates the sympathoexcitatory and hypertensive effects of high sodium intake in Dahl salt-sensitive rats. Circ Res 74: 586-595.
15. Huang BS, Leenen FH, (1998). Both brain angiotensin II and 'ouabain' contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake. Hypertension 32: 1028-1033.
16. Kapusta DR, Dayan LA, Kenigs VA, (2002). Nociceptin/orphanin FQ modulates the cardiovascular, but not renal, responses to stress in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 29: 254-259.
17. Lahdesmaki J, Sallinen J, MacDonald E, Scheinin M, (2004). Alpha2A-Adrenoceptors are important modulators of the effects of d-amphetamine on startle reactivity and brain monoamines. Neuropsychopharmacology 29: 1282-1293.
18. Menegaz RG, Kapusta DR, Mauad H, Cabral AM, (2001). Activation of alpha(2)-receptors in the rostral ventrolateral medulla evokes natriuresis by a renal nerve mechanism. Am J Physiol 281: R98-R107.
19. Miggin SM, Lawler OA, Kinsella BT, (2003). Palmitoylation of the human prostacyclin receptor. Functional implications of palmitoylation and isoprenylation. J Biol Chem 278: 6947-6958.
20. Nasman J, Kukkonen JP, Ammoun S, Akerman KE, (2001). Role of G-protein availability in differential signaling by alpha 2-adrenoceptors. Biochem Pharmacol 62: 913-922.
21. Olianas MC, Dedoni S, Onali P, (2007). Proteinase-activated receptors 1 and 2 in rat olfactory system: layer-specific regulation of multiple signaling pathways in the main olfactory bulb and induction of neurite retraction in olfactory sensory neurons. Neuroscience 146: 1289-1301.
22. Patel CB, Noor N, Rockman HA, (2010). Functional selectivity in adrenergic and angiotensin signalling systems. Mol Pharmacol 78: 983-992.
23. Paxinos G, Watson C, (1998). The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press: New York.
24. Raffa RB, Connelly CD, Chambers JR, Stone DJ, (1996). α-subunit G-protein antisense oligodeoxynucleotide effects on supraspinal (i.c.v.) α2-adrenoceptor antinocieption in mice. Life Sci 58: PL77-PL80.
25. Remaury A, Larrouy D, Daviaud D, Rouot B, Paris H, (1993). Coupling of the alpha 2-adrenergic receptor to the inhibitory G-protein Gi and adenylate cyclase in HT29 cells. Biochem J 292: 283-288.
26. Rossi GC, Standifer KM, Pasternak GW, (1995). Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci Lett 198: 99-102.
27. Ruffolo RR Jr, Nichols AJ, Stadel JM, Hieble JP, (1991). Structure and function of alpha-adrenoceptors. Pharmacol Rev 43: 475-505.
28. Scheinin M, Lomasney JW, Hayden-Hixson DM, Schambra UB, Caron MG, Lefkowitz RJ, et al,. (1994). Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res 21: 133-149.
29. Standifer KM, Rossi GC, Pasternak GW, (1996). Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits. Mol Pharmacol 50: 293-298.
30. Tavares A, Handy DE, Bogdanova NN, Rosene DL, Gavras H, (1996). Localization of alpha 2A- and alpha 2B-adrenergic receptor subtypes in brain. Hypertension 27: 449-455.
31. Wade SM, Lim WK, Lan KL, Chung DA, Namamori M, Neubig RR, (1999). G(i) activator region of alpha(2A)-adrenergic receptors: distinct basic residues mediate G(i) versus G(s) activation. Mol Pharmacol 56: 1005-1013.
32. Wainford RD, Kapusta DR, (2009). Chronic high-NaCl intake prolongs the cardiorenal responses to central N/OFQ and produces regional changes in the endogenous brain NOP receptor system. Am J Physiol 296: R280-R288.
33. Wainford RD, Kapusta DR, (2010). Hypothalamic paraventricular nucleus G alpha q subunit protein pathways mediate vasopressin dysregulation and fluid retention in salt-sensitive rats. Endocrinology 151: 5403-5414.
34. Wainford RD, Kurtz K, Kapusta DR, (2008). Central G-alpha subunit protein-mediated control of cardiovascular function, urine output, and vasopressin secretion in conscious Sprague-Dawley rats. Am J Physiol 295: R535-R542.
35. Watts VJ, Neve KA, (2005). Sensitization of adenylate cyclase by Galpha i/o-coupled receptors. Pharmacol Ther 106: 405-421.